James J. Chamberlain

1.3k total citations · 1 hit paper
17 papers, 913 citations indexed

About

James J. Chamberlain is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, James J. Chamberlain has authored 17 papers receiving a total of 913 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Surgery and 4 papers in Genetics. Recurrent topics in James J. Chamberlain's work include Diabetes Management and Research (12 papers), Diabetes Treatment and Management (5 papers) and Diabetes and associated disorders (4 papers). James J. Chamberlain is often cited by papers focused on Diabetes Management and Research (12 papers), Diabetes Treatment and Management (5 papers) and Diabetes and associated disorders (4 papers). James J. Chamberlain collaborates with scholars based in United States and Australia. James J. Chamberlain's co-authors include Andrew S. Rhinehart, Charles F. Shaefer, Jay H. Shubrook, NEIL SKOLNIK, Sandra Leal, William H. Herman, Rita R. Kalyani, Jennifer Trujillo, Eric L. Johnson and Maureen A. Murtaugh and has published in prestigious journals such as Annals of Internal Medicine, Clinical Rheumatology and Journal of Diabetes Science and Technology.

In The Last Decade

James J. Chamberlain

16 papers receiving 891 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diagnosis and Management of Diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes

2016 475 citations James J. Chamberlain, Andrew S. Rhinehart et al. Annals of Internal Medicine profile →

Peers

James J. Chamberlain

EDM

SURGE

CCM

EPIDE

Roberta Arnoldi Cobas Brazil

Marina V. Shestakova Russia

Aikaterini Kountouri Greece

Marc Ferrini France

Wayne Weng United States

A. D. Morris United Kingdom

Alessandra Saldanha de Mattos Matheus Brazil

Charles F. Shaefer United States

Frances Dockery United Kingdom

Eun Young Lee South Korea

Roberta Arnoldi Cobas Brazil

James J. Chamberlain

535 ×1.2

EDM

166 ×0.8

SURGE

176 ×1.1

CCM

160 ×1.1

112 ×0.9

EPIDE

Citations per year, relative to James J. Chamberlain James J. Chamberlain (= 1×) peers Roberta Arnoldi Cobas

Countries citing papers authored by James J. Chamberlain

Since Specialization

Citations

This map shows the geographic impact of James J. Chamberlain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James J. Chamberlain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James J. Chamberlain more than expected).

Fields of papers citing papers by James J. Chamberlain

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James J. Chamberlain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James J. Chamberlain. The network helps show where James J. Chamberlain may publish in the future.

Co-authorship network of co-authors of James J. Chamberlain

This figure shows the co-authorship network connecting the top 25 collaborators of James J. Chamberlain. A scholar is included among the top collaborators of James J. Chamberlain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James J. Chamberlain. James J. Chamberlain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Chamberlain, James J., et al.. (2020). Pharmacologic Approaches to Glycemic Treatment of Type 2 Diabetes: Synopsis of the 2020 American Diabetes Association's Standards of Medical Care in Diabetes Clinical Guideline. Annals of Internal Medicine. 173(10). 813–821. 83 indexed citations

Chamberlain, James J., et al.. (2020). Use of Diabetes-Related Applications and Digital Health Tools by People With Diabetes and Their Health Care Providers. Clinical Diabetes. 38(5). 449–461. 31 indexed citations

Chamberlain, James J., et al.. (2019). Diabetes Technology: Review of the 2019 American Diabetes Association Standards of Medical Care in Diabetes. Annals of Internal Medicine. 171(6). 415–420. 28 indexed citations

Chamberlain, James J., et al.. (2018). Cardiovascular Disease and Risk Management: Review of the American Diabetes Association Standards of Medical Care in Diabetes 2018. Annals of Internal Medicine. 168(9). 640–650. 68 indexed citations

Chamberlain, James J.. (2018). Continuous Glucose Monitoring Systems: Categories and Features. 8–10. 5 indexed citations

Chamberlain, James J., William H. Herman, Sandra Leal, et al.. (2017). Pharmacologic Therapy for Type 2 Diabetes: Synopsis of the 2017 American Diabetes Association Standards of Medical Care in Diabetes. Annals of Internal Medicine. 166(8). 572–578. 92 indexed citations

Chamberlain, James J., Rita R. Kalyani, Sandra Leal, et al.. (2017). Treatment of Type 1 Diabetes: Synopsis of the 2017 American Diabetes Association Standards of Medical Care in Diabetes. Annals of Internal Medicine. 167(7). 493–498. 51 indexed citations

Chamberlain, James J., et al.. (2016). Diagnosis and Management of Diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes. Annals of Internal Medicine. 164(8). 542–552. 475 indexed citations breakdown →

Chamberlain, James J., et al.. (2015). Impact of Frequent and Persistent Use of Continuous Glucose Monitoring (CGM) on Hypoglycemia Fear, Frequency of Emergency Medical Treatment, and SMBG Frequency After One Year. Journal of Diabetes Science and Technology. 10(2). 383–388. 18 indexed citations

10.

Chamberlain, James J., et al.. (2014). Rapid Improvement in Blood Glucose Control in a Patient With Type 1 Diabetes and Complete Blindness Using a Continuous Glucose Monitor. Clinical Diabetes. 32(4). 186–187. 1 indexed citations

11.

Chamberlain, James J., et al.. (2014). Do Perceptions of Insulin Pump Usability Impact Attitudes Toward Insulin Pump Therapy? A Pilot Study of Individuals With Type 1 and Insulin-Treated Type 2 Diabetes. Journal of Diabetes Science and Technology. 9(1). 105–110. 13 indexed citations

12.

Chamberlain, James J., et al.. (2013). Persistence of Continuous Glucose Monitoring Use in a Community Setting 1 Year After Purchase. Clinical Diabetes. 31(3). 106–109. 19 indexed citations

13.

Frech, Tracy, Gordon Smith, James J. Chamberlain, et al.. (2013). Peripheral neuropathy: a complication of systemic sclerosis. Clinical Rheumatology. 32(6). 885–888. 16 indexed citations

14.

Chamberlain, James J., et al.. (2012). Disrupting heteronormativity in schools. Open Collections. 1 indexed citations

15.

Chamberlain, James J., et al.. (2008). Successful Use of a Single Subcutaneous Continuous Glucose Monitor Sensor for 28 Days in a Patient with Type 1 Diabetes. Clinical Diabetes. 26(3). 138–139. 5 indexed citations

16.

Chamberlain, James J.. (2001). Advancing Rural Development. 5 indexed citations

17.

Guerny, Jacques du, et al.. (2000). From AIDS epidemics to an AIDS pandemic: is an HIV / AIDS hub building in South East Asia?. Medical Entomology and Zoology. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact